In the afternoon, the concept of innovative drugs in A-shares continued to rise, and Changchun High-Tech hit the daily limit. Previously, Sinocell, Jiuzhitang, Huahai Pharmaceutical, and Weiming Pharmaceutical hit the daily limit. Saisheng Pharmaceutical, Regeneron Biopharmaceuticals, Microchip Biopharmaceuticals, Maiwei Biopharma, and Guangshengtang rose by more than 7%.